1. Home
  2. HNI vs CRVS Comparison

HNI vs CRVS Comparison

Compare HNI & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo HNI Corporation

HNI

HNI Corporation

HOLD

Current Price

$36.30

Market Cap

2.5B

ML Signal

HOLD

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$15.23

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HNI
CRVS
Founded
1944
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Office Equipment/Supplies/Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
1.2B
IPO Year
1994
2016

Fundamental Metrics

Financial Performance
Metric
HNI
CRVS
Price
$36.30
$15.23
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$70.00
$28.20
AVG Volume (30 Days)
718.3K
996.4K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
3.86%
N/A
EPS Growth
N/A
48.04
EPS
1.11
N/A
Revenue
$2,839,000,000.00
N/A
Revenue This Year
$117.19
N/A
Revenue Next Year
$3.68
N/A
P/E Ratio
$31.69
N/A
Revenue Growth
12.37
N/A
52 Week Low
$31.41
$3.11
52 Week High
$53.29
$26.95

Technical Indicators

Market Signals
Indicator
HNI
CRVS
Relative Strength Index (RSI) 49.10 52.16
Support Level $33.72 $6.65
Resistance Level $47.41 $18.73
Average True Range (ATR) 1.17 0.90
MACD 0.68 0.24
Stochastic Oscillator 92.67 76.79

Price Performance

Historical Comparison
HNI
CRVS

About HNI HNI Corporation

HNI Corp is a provider of commercial furnishings and hearth products. Its two reportable segments are workplace furnishings and residential building products. The workplace furnishings segment includes furniture systems, seating, storage, tables, architectural products, ancillary products, and hospitality products. The residential building products segment includes various gas, wood, electric, and pellet-fueled fireplaces, inserts, stoves, facings, outdoor fire pits and fire tables, and accessories. The company's products are sold through independent dealers, distributors, eCommerce retailers, wholesalers, and retail outlets. A majority of the firm's revenue is generated from the Workplace furnishings segment. Geographically, it operates in the United States.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.

Share on Social Networks: